greeksoup/ stock research
Stock research / United States / AGIO / Documents

Agios Pharmaceuticals, Inc. documents

Agios Pharmaceuticals (AGIO) annual report: the 10-K filed 12 February 2026 for the year ended 31 December 2025. Proxy statement (DEF 14A) filed 24 April 2026; latest 10-Q filed 30 July 2026 for the quarter ended 30 June 2026. Each links to the document on EDGAR, with 4 earnings press releases.

Earnings press releases (exhibit 99 to each results 8-K)

FiledDocumentOpenWhere
30 July 2026Results press release, exhibit 99 to the 8-K filed 30 July 2026The releaseEDGAR folder
29 April 2026Results press release, exhibit 99 to the 8-K filed 29 April 2026The releaseEDGAR folder
12 February 2026Results press release, exhibit 99 to the 8-K filed 12 February 2026The releaseEDGAR folder
30 October 2025Results press release, exhibit 99 to the 8-K filed 30 October 2025The releaseEDGAR folder

Annual reports (10-K)

FiledDocumentOpenWhere
12 February 202610-K, period ended 31 December 2025The documentEDGAR folder

Quarterly reports (10-Q)

FiledDocumentOpenWhere
30 July 202610-Q, period ended 30 June 2026The documentEDGAR folder
29 April 202610-Q, period ended 31 March 2026The documentEDGAR folder
30 October 202510-Q, period ended 30 September 2025The documentEDGAR folder

Proxy statements

FiledDocumentOpenWhere
24 April 2026DEF 14A, period ended 18 June 2026The documentEDGAR folder

Annual report to shareholders

FiledDocumentOpenWhere
24 April 2026ARS, period ended 31 December 2025The documentEDGAR folder